HOME >> MEDICINE >> NEWS
7-day-on, 7-day-off regimen could reduce cost, toxicities of HIV therapy

A pilot study at the National Institute of Allergy and Infectious Diseases (NIAID) suggests that it may prove feasible for certain people with human immunodeficiency virus (HIV) disease to move from a continuous regimen of anti-HIV therapy to a strategy in which they discontinue and then resume anti-HIV therapy in a pre-planned, cyclic fashion.

This approach is known as "structured intermittent therapy." In the NIAID study, 10 patients received repeated "on-off" cycles of therapy: seven days of treatment with potent combinations of HIV medications, followed by seven days off the drugs. At the time of study enrollment, the patients were being successfully treated with continuous highly active antiretroviral therapy (HAART). For the study, they switched to the intermittent HAART regimen with no apparent deleterious effects on the course of their disease, and with a significant reduction in certain HAART-related side effects.

"Because it halves the total time during which patients receive anti-HIV medications, structured intermittent therapy could significantly reduce the costs and side effects of anti-HIV drugs, important issues in both resource-rich and poor countries," notes lead author Mark Dybul, M.D., NIAID assistant director for medical affairs. "It is important to stress, however, that the results of randomized, controlled clinical trials - currently under way - are needed to prove the benefits of this experimental approach before it can be recommended to patients outside the setting of a controlled clinical trial. Don't try this at home!"

The NIAID researchers, led by Dr. Dybul and NIAID Director Anthony S. Fauci, M.D., report their findings in the December 4 online early edition of the Proceedings of the National Academy of Sciences. The bulk of the research was conducted within the NIAID Laboratory of Immunoregulation, which Dr. Fauci directs and where Dr. Dybul is a staff clinician.

The authors note that HAART has
'"/>

Contact: Greg Folkers
gfolkers@nih.gov
301-496-2263
NIH/National Institute of Allergy and Infectious Diseases
3-Dec-2001


Page: 1 2 3

Related medicine news :

1. Study examines three-day antibiotic regimens for treating bladder infection in women
2. Study assessing once daily Abacavir (ABC) in a once daily ART regimen
3. Study compares three weekly regimens of chemotherapy for lung cancer
4. Vitamin E fails to join heart-health regimen
5. Newer lung cancer treatments extend survival longer than traditional regimens
6. New drug regimen shows clear benefit for treating advanced colorectal cancer
7. Emory University will conduct clinical trial of anthrax vaccine regimen
8. Drug regimen adherence key in keeping babies virus-free, study suggests
9. HIV patients more likely to accept a drug regimen if they trust in the physician, Yale researchers find
10. Are people with HIV sticking to their medication treatment regimens? New method measures patient adherence
11. Study compares efficacy and adherence to triple nucleoside therapy Ziagen + Combivir with protease inhibitor plus Combivir regimens in therapy-nave

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/15/2019)... ... March 15, 2019 , ... The National Association of Chain ... controlled substance prescriptions for Schedule II through Schedule VI, which will help prevent opioid ... will become effective January 1, 2021. , NACDS recognizes the leadership of ...
(Date:3/15/2019)... ... March 15, 2019 , ... The National Association of ... to a seven-day supply the initial prescriptions of opioids for acute pain – ... (CDC) guidelines for prescribing opioids. , U.S. Sen. Kirsten Gillibrand (D-NY) and U.S. ...
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... The ... Friday, March 15th at the Bellevue Club in Bellevue, Washington. GBM is short for ... EBCI and its sponsors and partners invite current and past brain cancer patients, survivors, ...
(Date:3/14/2019)... ... 14, 2019 , ... The National University System ... Sanford Harmony —today announced a new partnership with the Alliance for a ... lifelong healthy habits. The partnership will focus on building awareness of the integral ...
(Date:3/14/2019)... Va. (PRWEB) , ... March 14, 2019 , ... Cell ... FDA Approval, **An FDAnews Webinar**, Thursday, March 28, 2019, 1:30 p.m. - 3:00 p.m. ... approving 10 to 20 cell and gene therapy products a year. , That ...
Breaking Medicine News(10 mins):
(Date:3/12/2019)... ... March 13, 2019 , ... The nation's top provider of ... its upcoming workshops. The code to use for obtaining the discount is R3SCT500. , ... therapies having been performed to date. Last year, R3 began its first stem cell ...
(Date:3/12/2019)... ... March 12, 2019 , ... Global Lyme Alliance (GLA), ... research, education and awareness, today announced it has partnered with the state of ... course for physicians and other healthcare professionals. , This Continuing Medical Education ...
(Date:3/12/2019)... ... March 12, 2019 , ... Ventura County Board ... Health Champion at Work award. , Health Champion award recipients are recognized for ... making Ventura County the healthiest county in California. , Guided by a ...
Breaking Medicine Technology:
Cached News: